Literature DB >> 19789419

Hypokalemia, diabetes mellitus, and hypercortisolemia are the major contributing factors to cardiac dysfunction in adrenal Cushing's syndrome.

Sachiko Takagi1, Akiyo Tanabe, Mika Tsuiki, Mitsuhide Naruse, Kazue Takano.   

Abstract

Although cardiovascular complications are the major determinant of the prognosis of Cushing's syndrome (CS), factors contributing to the cardiovascular lesions are still unclear. We investigated clinical factors determining cardiac function in patients with adrenal CS. Fifty patients with adrenal CS were studied. Patients were divided into 3 groups based on their NYHA classification and electrocardiographic (ECG) findings: group A with NYHA grade 0 and normal ECG, group B with NYHA grade I and abnormal ECG, and group C with NYHA grade II or higher. Clinical and echocardiographic findings were compared between the groups. Heart failure of grade I or higher was seen in 40% and grade II or higher was seen in 8% of the patients. Age, HbA1c, and prevalence of diabetes mellitus were positively correlated and serum potassium levels were negatively correlated with the severity of cardiac dysfunction. Decreased ejection fraction (EF) and the ratio of the peak to late transmittal filling velocities (E/A), and increased left ventricular mass index (LVMI) were frequently observed. Multivariate analysis demonstrated that serum potassium and HbA1c levels were independent factors contributing to EF, while serum potassium and cortisol levels were independent factors contributing to LVMI. These results clearly demonstrated that hypokalemia, diabetes mellitus, and hypercortisolemia are the major contributing factors to cardiac dysfunction in adrenal CS. Strict control of these conditions is warranted for the prevention of cardiac dysfunction in adrenal CS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19789419     DOI: 10.1507/endocrj.k09e-198

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  7 in total

Review 1.  Medical suppression of hypercortisolemia in Cushing's syndrome with particular consideration of etomidate.

Authors:  Jens Heyn; Carolin Geiger; Christian L Hinske; Josef Briegel; Florian Weis
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

2.  The degree of urinary hypercortisolism is not correlated with the severity of cushing's syndrome.

Authors:  Valentina Guarnotta; Marco C Amato; Rosario Pivonello; Giorgio Arnaldi; Alessandro Ciresi; Laura Trementino; Roberto Citarrella; Davide Iacuaniello; Grazia Michetti; Chiara Simeoli; Annamaria Colao; Carla Giordano
Journal:  Endocrine       Date:  2016-03-10       Impact factor: 3.633

3.  The effect of glutathione treatment on the biochemical and immunohistochemical profile in streptozotocin-induced diabetic rats.

Authors:  Fatmagül Yur; Semiha Dede; Turan Karaca; Sevim Ciftçi Yegin; Yeter Değer; Hülya Ozdemir
Journal:  J Membr Biol       Date:  2013-05-17       Impact factor: 1.843

4.  Biventricular hypertrophy and heart failure as initial presentation of Cushing's disease.

Authors:  Thomas Morris Hey; Jordi Sanchez Dahl; Thomas Heiberg Brix; Eva Vad Søndergaard
Journal:  BMJ Case Rep       Date:  2013-11-01

Review 5.  Variability in laboratory parameters used for management of Cushing's syndrome.

Authors:  Francesca Pecori Giraldi; Alberto G Ambrogio
Journal:  Endocrine       Date:  2015-07-10       Impact factor: 3.633

6.  Adrenocortical Carcinoma Presenting as Reversible Dilated Cardiomyopathy.

Authors:  Mansoor C Abdulla
Journal:  Heart Views       Date:  2018 Apr-Jun

7.  Cardiac structure and function in Cushing's syndrome: a cardiac magnetic resonance imaging study.

Authors:  Peter Kamenický; Alban Redheuil; Charles Roux; Sylvie Salenave; Nadjia Kachenoura; Zainab Raissouni; Laurent Macron; Laurence Guignat; Christel Jublanc; Arshid Azarine; Sylvie Brailly; Jacques Young; Elie Mousseaux; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2014-08-05       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.